Gene · 406924
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Relationship Between Changes in the Expression Levels of miR-134 and E2F6 in Mediating Control of Apoptosis in NMDA-Induced Glaucomatous Mice. | J Invest Surg | 2024 | 39164010 | PubTator, text mining | PubMed |
| Unraveling the genetic basis of epilepsy: Recent advances and implications for diagnosis and treatment. | Brain Res | 2024 | 39032529 | PubTator, text mining | PubMed |
| BK Polyomavirus microRNA in Kidney Transplant Recipient. | Transplant Proc | 2024 | 38991903 | PubTator, text mining | PubMed |
| Elucidation of how the Mir-23-27-24 cluster regulates development and aging. | Exp Mol Med | 2024 | 38871817 | PubTator, text mining | PubMed |
| Identifying the differentially expressed peripheral blood microRNAs in psychiatric disorders: a systematic review and meta-analysis. | Front Psychiatry | 2024 | 38827444 | PubTator, text mining | PubMed |
| Extracellular vesicles secreted by 3D tumor organoids are enriched for immune regulatory signaling biomolecules compared to conventional 2D glioblastoma cell systems. | Front Immunol | 2024 | 38726003 | PubTator, text mining | PubMed |
| Retraction notice to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]. | EBioMedicine | 2024 | 38579362 | PubTator, text mining | PubMed |
Retraction notice to "Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]" [EBioMedicine 55 (2020) 102772]. | EBioMedicine | 2024 | 38579361 | PubTator, text mining | PubMed |
| Regulatory RNAs in immunosenescence. | Immun Inflamm Dis | 2024 | 38456619 | PubTator, text mining | PubMed |
| Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer. | Pathol Res Pract | 2024 | 38452582 | PubTator, text mining | PubMed |
| An essential role for the RNA helicase DDX6 in NMDA receptor-dependent gene silencing and dendritic spine shrinkage. | Sci Rep | 2024 | 38321143 | PubTator, text mining | PubMed |
| Editorial: DNA methylation, tumor microenvironment and their effects in immunotherapy and drug resistance in thoracic tumors. | Front Immunol | 2024 | 38288309 | PubTator, text mining | PubMed |
| Exploring the effect of LncRNA DANCR to regulate the Keap1-Nrf2/ARE pathway on oxidative stress in rheumatoid arthritis. | Immun Inflamm Dis | 2024 | 38270324 | PubTator, text mining | PubMed |
| Advances in Sjögren's Syndrome Dry Eye Diagnostics: Biomarkers and Biomolecules beyond Clinical Symptoms. | Biomolecules | 2024 | 38254680 | PubTator, text mining | PubMed |
| Emerging roles of exosomes in oral diseases progression. | Int J Oral Sci | 2024 | 38221571 | PubTator, text mining | PubMed |
| Differential microRNA editing may drive target pathway switching in human temporal lobe epilepsy. | Brain Commun | 2024 | 38204971 | PubTator, text mining | PubMed |
| Progress and application of adipose-derived stem cells in the treatment of diabetes and its complications. | Stem Cell Res Ther | 2024 | 38167106 | PubTator, text mining | PubMed |
| Dgcr8 functions in the secondary heart field for outflow tract and right ventricle development in mammals. | Dev Biol | 2024 | 38110169 | PubTator, text mining | PubMed |
| Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking. | Orthop Surg | 2024 | 38086608 | PubTator, text mining | PubMed |
| Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. | Transl Oncol | 2024 | 38042134 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406924/papers?page=3